NASDAQ$DHC
Diversified Heal · Q4 2025 earnings
Q4 2025 earnings · · After market close · Investor relations
Briefing
Diversified Healthcare Trust reported a narrower Q4 2025 net loss with stable total revenues and improved same property SHOP NOI and occupancy versus last year.
In Q4 2025, Diversified Healthcare Trust generated total revenues of 379571000 and reported a net loss of 21221000, while same property SHOP NOI increased materially year over year and Medical Office & Life Science occupancy improved.
- Total revenues were 379571000 for Q4 2025.
- Net loss was 21221000, or 0.09 per share.
- Same property SHOP cash basis NOI increased 27.6% year over year to 38291000.
- Adjusted EBITDAre was 72399000 in Q4 2025.
Headline financials
Revenue & EPS history
Diversified Heal · Revenue · Quarterly
$380M
Revenue by segment
Diversified Heal · $268M total across 1 segment · Q4 2022
- SHOP$268M+14.2%100.0%
Forward guidance
For full year 2026, DHC guided to total NOI of 297000000 to 313000000, Adjusted EBITDAre of 290000000 to 305000000, and Normalized FFO of 125000000 to 140000000 (0.52 to 0.58 per share).
Tailwinds
- SHOP NOI guidance of 175000000 to 185000000 for full year 2026.
- Medical Office / Life Science NOI guidance of 94000000 to 98000000 for full year 2026.
- Adjusted EBITDAre guidance of 290000000 to 305000000 for full year 2026.
- Normalized FFO guidance of 125000000 to 140000000 for full year 2026.
- Normalized FFO per common share guidance of 0.52 to 0.58 for full year 2026.
Headwinds
- Recurring capital expenditures expected at 100000000 to 115000000 for full year 2026.
- SHOP recurring capital expenditures expected at 80000000 to 90000000 for full year 2026.
- Mid-point general and administrative expense assumption of approximately 32500000.
- Mid-point interest expense assumption of approximately 149000000.
- Guidance assumes no acquisitions and no dispositions other than 13 communities under contract expected to close in March 2026.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2025
+0.9%
Avg return
Earnings day
+3.9%
Avg return
5 days after
+7.8%
Avg return
30 days after
50%
34 / 68 earnings
Positive
+51.0%
Q4 2022
Best reaction
-18.4%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.1% | +7.8% | +8.9% | |
| Q4 2025 | -2.3% | +9.9% | +11.7% | |
| Q3 2025 | +5.5% | +4.9% | +12.9% | |
| Q1 2025 | +30.7% | +38.5% | +50.5% | |
| Q4 2024 | +8.6% | +12.2% | +0.8% | |
| Q3 2024 | -18.4% | -24.2% | -25.9% | |
| Q2 2024 | -2.7% | -5.7% | +4.2% | |
| Q1 2024 | -11.8% | -13.4% | +13.7% | |
| Q4 2023 | +8.4% | +8.8% | -18.6% | |
| Q3 2023 | +7.2% | +7.7% | +28.0% | |
| Q2 2023 | +12.0% | +29.2% | +30.1% | |
| Q1 2023 | +0.6% | +0.0% | +163.6% | |
| Q4 2022 | +51.0% | +82.7% | +37.8% | |
| Q3 2022 | -13.2% | -5.9% | -27.2% | |
| Q2 2022 | +1.2% | +9.9% | -16.3% | |
| Q1 2022 | +6.9% | +0.0% | -1.8% | |
| Q4 2021 | -4.5% | -7.1% | -2.6% | |
| Q3 2021 | -10.3% | -7.1% | -29.7% | |
| Q2 2021 | +1.8% | +1.3% | -3.1% | |
| Q1 2021 | -7.1% | -6.4% | -13.9% | |
| Q4 2020 | +0.9% | +1.5% | +6.7% | |
| Q3 2020 | -6.3% | +27.0% | +49.5% | |
| Q2 2020 | +6.9% | +3.8% | -5.5% | |
| Q1 2020 | +8.7% | -2.0% | +104.7% | |
| Q4 2019 | +6.7% | -0.3% | -52.9% | |
| Q3 2019 | -8.7% | -14.8% | -16.0% | |
| Q2 2019 | +6.7% | +8.2% | +3.8% | |
| Q1 2019 | +2.3% | +2.3% | +1.5% | |
| Q4 2018 | -8.2% | -8.6% | -9.0% | |
| Q3 2018 | -2.7% | -0.2% | -15.9% | |
| Q2 2018 | +0.9% | -2.6% | +3.6% | |
| Q1 2018 | +2.0% | +1.7% | +9.5% | |
| Q4 2017 | -4.3% | -2.8% | -1.0% | |
| Q3 2017 | +1.1% | +1.9% | +0.4% | |
| Q2 2017 | -1.8% | -1.1% | +2.9% | |
| Q1 2017 | -1.1% | -0.5% | +3.2% | |
| Q4 2016 | +1.5% | +1.6% | +0.7% | |
| Q3 2016 | -1.8% | -5.6% | -8.1% | |
| Q2 2016 | -2.4% | -1.1% | +2.7% | |
| Q1 2016 | +2.4% | — | — | |
| Q4 2015 | +0.4% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | -1.2% | — | — | |
| Q1 2015 | -1.0% | — | — | |
| Q4 2014 | -0.4% | — | — | |
| Q3 2014 | -1.5% | — | — | |
| Q2 2014 | -1.5% | — | — | |
| Q1 2014 | -0.7% | — | — | |
| Q4 2013 | +4.3% | — | — | |
| Q3 2013 | -1.2% | — | — | |
| Q2 2013 | -4.7% | — | — | |
| Q1 2013 | -0.6% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q3 2012 | +1.5% | — | — | |
| Q2 2012 | -0.8% | — | — | |
| Q1 2012 | +0.1% | — | — | |
| Q4 2011 | -1.3% | — | — | |
| Q4 2010 | -1.3% | — | — | |
| Q3 2011 | -2.9% | — | — | |
| Q2 2011 | +0.6% | — | — | |
| Q1 2010 | -2.5% | — | — | |
| Q1 2011 | -0.1% | — | — | |
| Q4 2008 | +4.0% | — | — | |
| Q3 2010 | +1.7% | — | — | |
| Q3 2009 | +1.7% | — | — | |
| Q2 2010 | +1.3% | — | — | |
| Q2 2009 | +1.3% | — | — | |
| Q4 2009 | +1.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro